Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs O'Reilly Automotive Inc. Common Stock (ORLY) Price & Performance

Moderna, Inc.Trade
O'Reilly Automotive Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs O'Reilly Automotive Inc. Common Stock — how do they compare? Moderna, Inc. trades at $195.81 (market cap $78.44B), while O'Reilly Automotive Inc. Common Stock trades at $85.91 (market cap $68.45B). The key difference: Moderna, Inc. and O'Reilly Automotive Inc. Common Stock are close in size by market cap, and Moderna, Inc. is trading nearer its 52-week high, O'Reilly Automotive Inc. Common Stock nearer its low. Which is the better fit depends on your goals.

MRNAORLY
Market Cap
$78.44B$68.45B
Volume
14,597,5116,667,530
Sector
HealthConsumer Cyclical
52-Week High
$203.46$103.05
52-Week Low
$22.36$82.73
Typical Hold Time
59 Days—
Enterprise Value
$74.59B$77.77B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

Moderna (MRNA) trades at $196.48, up 4.81% amid Nasdaq-100 inclusion news, though it remains well below the analyst consensus target of $115.70. The stock shows bullish technical momentum with recent earnings beats, but faces fundamental challenges with negative profit margins and declining revenue from pandemic-era highs. The company's cash flow improved in 2025, turning positive for the first time since 2022, while its pipeline, including oncology vaccines, attracts investor interest despite valuation concerns.

Outlook: Near-term momentum from index fund buying and pipeline updates may support the stock, but high valuation multiples and persistent losses pose significant risks. Long-term growth depends on successful commercialization of non-COVID products, with current prices reflecting optimistic scenarios. Investors should weigh the potential of the mRNA platform against execution risks and competitive pressures.

O'Reilly Automotive Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRNA
29% Buy71% Sell
Avg holding period · 59 Days
ORLY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →

About O'Reilly Automotive Inc. Common Stock

O'Reilly Automotive sells automotive aftermarket parts, tools, supplies, equipment, and accessories. It serves both professional service providers and do-it-yourself customers through its store network.

Read more on ORLY →